Sanyo Chemical’s Silk-Elastin Shows Promise in Meniscus Regeneration Clinical Trial Results Published in Scientific Reports－ Seeking U.S. Partners for Market Entry －
- 2025/02/13 News
KYOTO, JAPAN — [February 13, 2025] —Sanyo Chemical’s Silk-Elastin, a novel regenerative medicine material, has demonstrated promising results in clinical trials for meniscus regeneration. Findings published in Scientific Reports validate its safety and efficacy, highlighting its potential as a groundbreaking regenerative treatment for meniscus injuries and paving the way for FDA approval and commercialization in the U.S. To bring this innovative meniscus repair treatment to market, Sanyo Chemical is seeking marketing and distribution partners in the U.S.